Inmed Pharmaceuticals Inc Stock Annual Yield
| MWG0 Stock | 3.94 0.20 4.83% |
INMED PHARMACEUTICALS INC fundamentals help investors to digest information that contributes to INMED PHARMACEUTICALS's financial success or failures. It also enables traders to predict the movement of INMED Stock. The fundamental analysis module provides a way to measure INMED PHARMACEUTICALS's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to INMED PHARMACEUTICALS stock.
INMED |
INMED PHARMACEUTICALS INC Company Annual Yield Analysis
INMED PHARMACEUTICALS's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
In accordance with the recently published financial statements, INMED PHARMACEUTICALS INC has an Annual Yield of 0.0%. This indicator is about the same for the average (which is currently at 0.0) sector and about the same as Annual Yield (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
INMED Annual Yield Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses INMED PHARMACEUTICALS's direct or indirect competition against its Annual Yield to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of INMED PHARMACEUTICALS could also be used in its relative valuation, which is a method of valuing INMED PHARMACEUTICALS by comparing valuation metrics of similar companies.INMED PHARMACEUTICALS is currently under evaluation in annual yield category among its peers.
About INMED PHARMACEUTICALS Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze INMED PHARMACEUTICALS INC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of INMED PHARMACEUTICALS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of INMED PHARMACEUTICALS INC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in INMED Stock
INMED PHARMACEUTICALS financial ratios help investors to determine whether INMED Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in INMED with respect to the benefits of owning INMED PHARMACEUTICALS security.